Primary Site >> Colorectal Cancer

Gene >> SLC51A

Journal: Biochem Pharmacol. 2006 Sep 14;72(6):729-38.
Title: Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps.
Author: Ballestero, Maria R|Monte, Maria J|Briz, Oscar|Jimenez, Felipe|Gonzalez-San Martin, Francisco|Marin, Jose J G
PMID: 16844096
Journal: Mol Pharm. 2012 Sep 4;9(9):2565-76.
Title: Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.
Author: Herraez, Elisa|Gonzalez-Sanchez, Ester|Vaquero, Javier|Romero, Marta R|Serrano, Maria A|Marin, Jose J G|Briz, Oscar
PMID: 22800197
Journal: J Surg Res. 2013 May;181(2):242-9.
Title: Osteoporosis self-assessment tool for Asians as a simple risk index of identifying a poor prognosis in women surgically treated for colorectal cancer.
Author: Chen, Chao-Wen|Tsai, Hsiang-Lin|Yeh, Yung-Sung|Lin, Hsing-Lin|Huang, Ching-Wen|Chen, Chin-Fan|Chang, Yu-Tang|Lou, Yun-Ting|Wang, Jaw-Yuan
PMID: 22819312
Journal: Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1044-51.
Title: microRNA-192 suppresses the expression of the farnesoid X receptor.
Author: Krattinger, Regina|Bostrom, Adrian|Schioth, Helgi B|Thasler, Wolfgang E|Mwinyi, Jessica|Kullak-Ublick, Gerd A
PMID: 27079614